USMLE Step 1 practice question: Positive predictive value and the effect of prevalence (2 × 2 table)

USMLE Step 1BiostatisticsBiostatistics

Investigators evaluate a new rapid serum antibody assay for celiac disease. In a referral study, the assay is performed in 1,000 consecutive patients referred to a gastroenterology center for suspected celiac disease, all of whom undergo duodenal biopsy as the reference standard. Biopsy confirms celiac disease in 250 patients. The assay is positive in 225 of the patients with celiac disease and in 75 of the patients without celiac disease. The assay is then introduced in a primary care network, where the prevalence of celiac disease among tested patients is 10%. Assume that the sensitivity and specificity of the assay are the same in both settings.

What is the probability that a primary care patient with a positive assay result has celiac disease?

  1. 10%
  2. 25%
  3. 50%
  4. 75%
  5. 90%
Show answer and explanation

Correct answer: C. 50%

Step 1 – Build the 2 × 2 table for the referral study (N = 1,000; 250 with disease, 750 without disease): • True positives (TP) = 225; false negatives (FN) = 250 − 225 = 25 • False positives (FP) = 75; true negatives (TN) = 750 − 75 = 675

Sensitivity = TP / (TP + FN) = 225 / 250 = 90%. Specificity = TN / (TN + FP) = 675 / 750 = 90%. (In the referral population, PPV = 225 / (225 + 75) = 225 / 300 = 75%, and NPV = 675 / (675 + 25) = 675 / 700 ≈ 96%.)

Step 2 – Apply the same sensitivity and specificity to the primary care population (prevalence 10%). Using a hypothetical 1,000 patients: • With disease: 100 → TP = 0.90 × 100 = 90; FN = 10 • Without disease: 900 → TN = 0.90 × 900 = 810; FP = 900 − 810 = 90

PPV = TP / (TP + FP) = 90 / (90 + 90) = 90 / 180 = 50%. (NPV = 810 / (810 + 10) = 810 / 820 ≈ 99%.)

Key concept: Sensitivity and specificity are intrinsic properties of a test and do not change with prevalence (assuming a similar spectrum of disease). Predictive values, however, depend on prevalence: as prevalence decreases, PPV decreases (false positives become more numerous relative to true positives) and NPV increases. Thus the same assay with 90% sensitivity and 90% specificity has a PPV of 75% in a referral center (prevalence 25%) but only 50% in primary care (prevalence 10%). The question asks for the probability of disease given a positive result, which is the definition of PPV.

High-yield summary: PPV = TP / (TP + FP); ↓prevalence → ↓PPV and ↑NPV; sensitivity and specificity are unaffected by prevalence.

Why the other options are wrong

  • A. 10% — 10% is the prevalence (pretest probability) of celiac disease in primary care. A positive result raises the probability above the pretest value; PPV = 90 / 180 = 50%.
  • B. 25% — 25% is the prevalence in the referral study (250 / 1,000), which is neither the pretest probability in primary care nor a predictive value.
  • D. 75% — 75% is the PPV in the referral population (225 / 300), where prevalence was higher. PPV falls when the same test is applied to a lower-prevalence population.
  • E. 90% — 90% is the sensitivity (225 / 250) and also the specificity (675 / 750) of the assay. Sensitivity is the probability of a positive test given disease, not the probability of disease given a positive test.

Key point

Positive predictive value (TP / [TP + FP]) depends on disease prevalence: applying a test with fixed sensitivity and specificity to a lower-prevalence population lowers PPV and raises NPV.

Memory hook

PPV follows Prevalence — the P's rise and fall together; NPV moves opposite. Sensitivity and specificity don't budge. Rarer disease → more false positives.

Share: Telegram WhatsApp X LinkedIn

Practice like this every day

15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.

Play free

More free questions in this system

Case-control study: calculating the odds ratioUSMLE Step 1 · BiostatisticsIntention-to-treat analysis preserves randomization in clinical trialsUSMLE Step 2 CK · BiostatisticsChronic aortic regurgitationUSMLE Step 1 · CardiovascularPharmacokinetics: volume of distribution and oral loading doseUSMLE Step 1 · PharmacologyAutosomal recessive recurrence risk (cystic fibrosis, unaffected sibling = 2/3 carrier)USMLE Step 1 · GeneticsAcyclovir-resistant HSV: thymidine kinase deficiencyUSMLE Step 1 · Microbiology

All free questions →